We are live on
!
Find out more
PHS
PFM Health Sciences Portfolio holdings
AUM
$1.1B
1-Year Est. Return
57.92%
This Fund
S&P 500
This Quarter
Est. Return
+12.48%
1 Year Est. Return
+57.92%
3 Year Est. Return
+183.93%
5 Year Est. Return
+283%
10 Year Est. Return
+2,507.28%
AUM
$3.63B
AUM Growth
-$655M
(-15%)
Cap. Flow
-$792M
Cap. Flow
% of AUM
-21.84%
Top 10 Holdings %
Top 10 Hldgs %
31.08%
Holding
113
New
24
Increased
24
Reduced
34
Closed
30
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Jazz Pharmaceuticals
JAZZ
|
+$90.1M |
| 2 |
AerCap
AER
|
+$80M |
| 3 |
Pfizer
PFE
|
+$73.2M |
| 4 |
Illumina
ILMN
|
+$56.4M |
| 5 |
Equifax
EFX
|
+$54M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$262M |
| 2 |
Vulcan Materials
VMC
|
+$208M |
| 3 |
Bausch Health
BHC
|
+$108M |
| 4 |
AGN
Allergan Inc
AGN
|
+$107M |
| 5 |
AGN
Allergan plc
AGN
|
+$82.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 49.17% |
| 2 | Industrials | 10.32% |
| 3 | Materials | 6.21% |
| 4 | Technology | 5.36% |
| 5 | Financials | 3.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Amazon
AMZN
$2.92T
| $7.25M | 0.2% |
+389,940
| New | +$6.86M |
|
|
EIGR
77
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
| $3.16M | 0.09% |
370
-645
| -64% | -$5.64M |
|
78
PTC Therapeutics
PTCT
$5.68B
| $3.12M | 0.09% |
51,329
-79,770
| -61% | -$4.87M |
|
|
PRAH
79
DELISTED
PRA Health Sciences, Inc.
PRAH
| $2.15M | 0.06% |
74,390
-219,125
| -75% | -$6.11M |
|
80
CALL
State Street Financial Select Sector SPDR ETF
XLF
$56.7B
| $1.2M | 0.03% |
+8,833,166
| New | +$187M |
|
81
CALL
Gilead Sciences
GILD
$162B
| $670K | 0.02% |
+740,800
| New | +$75.2M |
|
82
Cognizant
CTSH
$24.9B
| $3K | ﹤0.01% |
+50
| New | +$2.95K |
|
83
Advance Auto Parts
AAP
$3.35B
| – | – |
-398,576
| Closed | -$63.5M |
|
84
Adobe
ADBE
$99.5B
| – | – |
-1,089,475
| Closed | -$79.2M |
|
85
Amgen
AMGN
$208B
| – | – |
-300,898
| Closed | -$47.9M |
|
86
Bank of America
BAC
$435B
| – | – |
-1,434,438
| Closed | -$25.7M |
|
87
Baidu
BIDU
$37.7B
| – | – |
-146,036
| Closed | -$33.3M |
|
88
PUT
Bristol-Myers Squibb
BMY
$133B
| – | – |
-2,707,300
| Closed | -$262K |
|
89
Charter Communications
CHTR
$17.3B
| – | – |
-298,683
| Closed | -$49.8M |
|
90
Community Health Systems
CYH
$393M
| – | – |
-363,065
| Closed | -$16.2M |
|
|
HAPN
91
Happen Inc
HAPN
$2.21B
| – | – |
-12,998
| Closed | -$1.64M |
|
92
CALL
Merck
MRK
$322B
| – | – |
-3,674,183
| Closed | -$332K |
|
|
93
Merck
MRK
$322B
| – | – |
-745,655
| Closed | -$40.4M |
|
|
94
Microsoft
MSFT
$3.45T
| – | – |
-5,636,799
| Closed | -$262M |
|
95
NVIDIA
NVDA
$4.86T
| – | – |
-29,057,200
| Closed | -$14.6M |
|
96
Pultegroup
PHM
$24.1B
| – | – |
-2,733,132
| Closed | -$58.7M |
|
97
Qualcomm
QCOM
$155B
| – | – |
-447,578
| Closed | -$33.3M |
|
98
Thermo Fisher Scientific
TMO
$213B
| – | – |
-419,210
| Closed | -$52.5M |
|
99
Visa
V
$684B
| – | – |
-792,916
| Closed | -$52M |
|
100
Vipshop
VIPS
$7.37B
| – | – |
-2,946,157
| Closed | -$57.6M |
|
Similar funds
DAM
MAM
LCM
DAM
KCM
CF
MIA
YL
PFM Health Sciences's Q1 2015 Portfolio in Review
As of Q1 2015, PFM Health Sciences held 113 positions worth $3.63B, down 15% from $4.28B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
PFM Health Sciences withdrew a net $792M in Q1 2015, closing 30 positions and reducing 34 holdings. Its most notable exit was Microsoft, an estimated $262M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 49% of assets, down from 50% a quarter earlier, followed by Industrials and Materials.
Against the trend, PFM Health Sciences opened a new position in Jazz Pharmaceuticals worth $90.7M.
- PFM Health Sciences's largest Q1 2015 buy was Jazz Pharmaceuticals: 525,003 shares worth $90.7M.
- PFM Health Sciences added most to AerCap in Q1 2015, an estimated $80M increase.
- PFM Health Sciences's biggest Q1 2015 reduction was Vulcan Materials, cutting an estimated $208M.
- PFM Health Sciences fully exited Microsoft in Q1 2015, selling an estimated $262M.
- PFM Health Sciences's ten largest holdings make up 31% of its $3.63B portfolio in Q1 2015.
- PFM Health Sciences opened 24 new positions and closed 30 in Q1 2015.
- PFM Health Sciences's portfolio value fell 15% quarter-over-quarter to $3.63B.
Based on PFM Health Sciences's 13F filing for Q1 2015, filed 15 May 2015.